Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Trial Evaluating Induction Therapy With Idarubicin and Etoposide Plus Sequential or Concurrent Azacitidine and Maintenance Therapy With Azacitidine (azacitidine)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01180322
Recruitment Status : Completed
First Posted : August 12, 2010
Last Update Posted : December 31, 2020
Sponsor:
Information provided by (Responsible Party):
Prof. Dr. Richard Schlenk, University of Ulm

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : June 2012
Actual Study Completion Date : October 2, 2016